Pharmacologic management of obscure gastrointestinal bleeding

Techniques in Gastrointestinal Endoscopy

Volumn 5, Issue 3, 2003, Pages 142-145

  Cheng, Michael W ^a   Madanick, Ryan ^a   Barkin, Jamie S ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; CONJUGATED ESTROGEN; CORTICOSTEROID; DANAZOL; DESMOPRESSIN; ESTROGEN; ETHINYLESTRADIOL; HEMOSTATIC AGENT; IMMUNOGLOBULIN; IRON; MESTRANOL; MESTRANOL PLUS NORETHISTERONE; MESTRANOL PLUS NORETYNODREL; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; NORETYNODREL; OCTREOTIDE; PLACEBO; PROGESTERONE; RECOMBINANT ERYTHROPOIETIN; SOMATOSTATIN; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD TRANSFUSION; CAUTERIZATION; CLINICAL TRIAL; CRYOPRECIPITATION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SURGERY; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY; MICROANGIOPATHY; RENDU OSLER WEBER DISEASE; TELANGIECTASIA; TRANSDERMAL PATCH;

EID: 0345874624     PISSN: 10962883     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tgie.2003.10.005     Document Type: Article

References (39)

1. Lewis BS: Small intestinal bleeding. Gastroenterol Clin North Am 29:67-95, 2000
2. Rockey DC: Occult gastrointestinal bleeding. N Engl J Med 341:38-46, 1999
3. Koch HJ, Escher GC, Lewis JS: Hormonal management of hereditary hemorrhagic telangiectasia. JAMA 149:1376-1380, 1952
4. McGee RR: Estrogen-progestogen therapy for gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. South Med J 72:1503, 1979
5. Vase P: Estrogen treatment of hereditary hemorrhagic telangiectasia. Acta Med Scand 209:393-396, 1981
6. Liu YK, Kosfield RE, Marcum SG: Treatment of uraemic bleeding with conjugated oestrogen. Lancet 2:887-890, 1984
7. Livio M, Mannucci PM, Vigano G, Mingardi G, Lombardi R, Mecca G, Remuzzi G: Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 315:731-735, 1986
8. Bronner MH, Pate MB, Cunningham JT, Marsh WH: Estrogen-progesterone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure: an uncontrolled trial. Ann Intern Med 105:371-374, 1986
9. Granieri R, Mazzulla JP, Yarborough GW: Estrogen-progesterone therapy for recurrent gastrointestinal bleeding secondary to gastrointestinal angiodysplasia. Am J Gastroenterol 83:556-558, 1988
10. Chey WD, Hasler WL, Bockenstedt PL: Angiodysplasia and von Willebrand's disease type IIB treated with estrogen/progesterone therapy. Am J Hematol 41:276-279, 1992
11. Lavabre-Bertrand T, Navarro MVon Willebrand's disease, digestive angiodysplasia, and estrogen-progesterone treatment [letter]: Am J Hematol 46:254-255, 1994
12. Lewis B, Kornbluth A, Waye J: Small bowel arteriovenous malformations as a cause of obscure gastrointestinal bleeding: Response to hormonal therapy. Gastroenterology 96:A298, 1989 (abstr)
13. Van Cutsem E, Rutgeerts P, Vantrappen G: Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet 335:953-955, 1990
14. Lewis BS, Salomon P, Rivera-MacMurray S, Kornbluth AA, Wenger J, Waye JD: Does hormonal therapy have any benefit for bleeding angiodysplasia? J Clin Gastroenterol 15:99-103, 1992
15. Barkin JS, Ross BS: Medical therapy for chronic gastrointestinal bleeding of obscure origin. Am J Gastroenterol 93:1250-1254, 1998
16. Junquera F, Feu F, Papo M, Videla S, Armengol JR, Bordas JM, Saperas E, Pique JM, Malagelada J-R: A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology 121:1073-1079, 2001
17. Lewis BS, Kornbluth A: Hormonal therapy for bleeding angiodysplasia: Chronic renal failure [letter]. Am J Gastroenterol 85:1649-1651, 1990
18. Madanick RD, Barkin JS: Hormonal therapy in angiodysplasia: Should we completely abandon its use? [letter] Gastroenterology 123:2156, 2002
19. Van Cutsem E, Rutgeerts P, Coremans G, Vantrappen G, et al: Dose-response study of hormonal therapy in bleeding gastrointestinal malformations. Gastroenterology 104:A286, 1993 (abstr)
20. Menefee MG, Flessa HC, Glueck HI, Hogg SP: Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): an electron microscopic study of the vascular lesions before and after therapy with hormones. Arch Otolaryngol 101:246-251, 1975
21. Sloand JA, Schiff MJ: Beneficial effect of low-dose transdermal estrogen on bleeding time and clinical bleeding in uremia. Am J Kidney Dis 26:22-26, 1995
22. Tulassay Z: Somatostatin and the gastrointestinal tract. Scand J Gastroenterol 33 suppl 228:115-121, 1998
23. Rossini FP, Arrigoni A, Pennazio M: Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine. Am J Gastroenterol 88:1424-1427, 1993
24. Andersen MR, Aaseby J: Somatostatin in the treatment of gastrointestinal bleeding caused by angiodysplasia. Scand J Gastroenterol 31:1037-1039, 1996
25. Piessevaux H, Coremans G, Rutgeerts P, et al: Octreotide in the treatment of bleeding gastrointestinal vascular malformations. Gastroenterology 110:A353, 1996 (abstr)
26. Nardone G, Rocco A, Balzano T, Budillon G: The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 13:1429-1436, 1999
27. Bowers M, McNulty O, Mayne E: Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease. Br J Haematol 108:524-527, 2000
28. Nordquist LT, Wallach PM: Octreotide for gastrointestinal bleeding of obscure origin in an anticoagulated patient [letter]. Dig Dis Sci 47:1514-1515, 2002
29. Prentice CR: Basis of antifibrinolytic therapy. J Clin Pathol 14:35-40, 1980 (suppl)
30. Graham DR, Walker RJ: Persistent gastrointestinal bleeding successfully treated with aminocaproic acid. Postgrad Med J 58:658-661, 1982
31. Saba HI, Morelli GA, Logrono LA: Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. N Engl J Med 330:1789-1790, 1994
32. Quitt M, Froom P, Veisler A, Falber V, Sova J, Aghai E: The effect of desmopressin on massive gastrointestinal bleeding in hereditary telangiectasia unresponsive to treatment with cryoprecipitate. Arch Intern Med 150:1744-1746, 1990
33. Haq AU, Glass J, Netchvolodoff CV, et al: Hereditary hemorrhagic telangiectasia and danazol [letter]. Ann Intern Med 109:171, 1988
34. Korzenik JR, Topazian M: Danazol in the treatment of GI hemorrhage secondary to hereditary hemorrhagic telangiectasia. Gastroenterology 108:A297, 1995 (abstr)
35. Wagner DD: Structure and biology of von Willebrand factor, in Hoffman R, Benz EJ Jr, Shattil SJ, et al (eds): Hematology: Basic Principles and Practice (ed 1). New York, NY, Churchill Livingstone, 1991, pp 1354-1358
36. Van Wyck DB: Iron management during recombinant human erythropoietin therapy. Am J Kidney Dis 14:9-13, 1989 (suppl 1)
37. Zaharia-Czeizler V: Erythropoietin stops chronic diffuse transfusion-dependent gastrointestinal bleeding [letter]. Ann Intern Med 135:933, 2001
38. Zuckerman GR, Prakash C, Askin MP, et al: AGA technical review on the evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology 118:201-221, 2000
39. Humphries KH, Gill S: Risks and benefits of hormone replacement therapy: the evidence speaks. CMAJ 168:1001-1010, 2003